About this trial
The goal of this clinical trial is to find new ingredients for oral care products that can improve gum health. We want to learn if new botanical blends can help reduce gum inflammation, strengthen the gum's natural barrier, and lessen dry mouth symptoms. This study will also look at how these ingredients affect the helpful bacteria in the mouth (oral microbiome) and overall oral health.
Researchers will compare different botanical blends against a control group that uses a simple mouthwash without the active ingredients to see their effects.
Participants will use a simple mouthwash daily for 14 days. This mouthwash will contain either one of two botanical ingredients, a combination of both, or no active ingredient (a control). During the study participants will complete questionnaires about their quality of life and any dry mouth symptoms at home and provide samples of saliva and fluid from their gums at different times during the study to check for changes in their oral microbiome and inflammation levels.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Healthy Adults
Disqualifiers
Women who are pregnant, breastfeeding, or planning to become pregnant during the study period
Known allergy or hypersensitivity to any of the study materials or ingredients
Current smokers or individuals who have used tobacco products (including smokeless tobacco) within the last 6 months
Antibiotic use within 3 months of study start
Trial design
Factorial
Treatments tested in this trial
Botanical A
Dietary supplementThe intervention involves the daily use of a mouth rinse twice daily for 14 days. This mouthwash will contain proprietary botanical, "Botanical A"
Botanical B
Dietary supplementThe intervention involves the daily use of a mouth rinse twice daily for 14 days. This mouthwash will contain proprietary botanical, "Botanical B"
Vehicle (Placebo solution)
Dietary supplementThe intervention involves the daily use of a mouth rinse twice daily for 14 days. This mouthwash will not contain any botanicals - vehicle control
Treatment groups
Trial outcomes
Primary outcomes
Change from Baseline in Gingival Inflammation as Measured by Modified Gingival Index
Change from Baseline in Gingival Inflammation as Measured by Bleeding on Probing
Change from Baseline in Oral Microbiome Composition and Diversity as Assessed by 16S rRNA Sequencing of Saliva and Gingival Crevicular Fluid Samples
Change from Baseline in Self-Reported Dry Mouth Symptoms as Assessed by the Oral Health Impact Profile-14 (OHIP-14)
Secondary outcomes
Change from Baseline in Gum Barrier Integrity and Inflammatory Response as Assessed by Gene Expression Analysis from Oral Mucosal Swabs
Other outcomes
Change from Baseline in Salivary Composition as Measured by pH
Change from Baseline in Salivary Composition as Measured by Buffering Capacity
Change from Baseline in Salivary Composition as Measured by Flow Rate
Change from Baseline in Gum Redness as Quantified by Image Analysis of Oral Photographs Under Standard Conditions
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: